MTOR and cancer: ECHS1 oxidizes fatty acids (FAs) and branched-chain amino acids (BCAAs), which removes their activation of mammalian target of rapamycin (mTOR) signaling, a well-established factor that drives increased protein synthesis and mitochondrial biogenesis in cancer.